Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasm, Residual × Docosahexaenoic Acids × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 4 Melanoma 3 Polycystic Ovary Syndrome 2 Obesity 2 Smoldering Multiple Myeloma 1 Sarcopenia 1 Psoriasis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Overweight 1 Osteoarthritis 1 Non-alcoholic Fatty Liver Disease 1 Neoplasms 1 Nasopharyngeal Carcinoma 1 Multiple Myeloma 1 Monoclonal Gammopathy of Undetermined Significance 1 Liver Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Autoimmune Diseases 1 Arthritis, Rheumatoid 1

Interventions

Cyclophosphamide 11 blinatumomab 8 fludarabine 7 venetoclax 6 fludarabine phosphate 5 Cytarabine 5 Rituximab 4 Lenalidomide 4 Dexamethasone 4 Blood Specimen Collection 4 Azacitidine 4 obinutuzumab 3 daratumumab 3 pembrolizumab 2 nilotinib 2 Vincristine 2 Radiotherapy 2 Methotrexate 2 Melphalan 2 Immunotherapy, Adoptive 2 Imatinib Mesylate 2 Idarubicin 2 Daunorubicin 2 Dasatinib 2 Chemotherapy, Adjuvant 2 trastuzumab deruxtecan 1 tislelizumab 1 tisagenlecleucel 1 thymoglobulin 1 tetrathiomolybdate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡